Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hiossen is a dental implant and restorative dentistry company focused on implant systems, prosthetics, surgical kits, biomaterials, digital dentistry tools, and related clinical education. Founded in the United States in 2006 by parent company Osstem, the business has grown into a commercial-stage dental medical device company serving clinicians through a broad implant portfolio and practice-support offerings. Its products include multiple implant systems such as EK, ET, SS, and EM, along with guided surgery, prosthetic components, oral care materials, and dental equipment. Hiossen also emphasizes domestic U.S. manufacturing in Pennsylvania, in-house surface treatment and sterilization capabilities, and global distribution through Osstem-affiliated operations. The company is best understood as a commercial dental implant platform business rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hiossen.